Announcement of Resolutions of the First Meeting of the Fifth Board of Directors of Kangchen Pharmaceutical
Securities code: 603590 Securities abbreviation: Kangchen Pharmaceutical Announcement number: Lin 2026-002
Beijing Kangchen Pharmaceutical Co., Ltd.
Announcement of Resolutions of the First Meeting of the Fifth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening of board of directors meetings
The first meeting of the fifth board of directors of Beijing Kangchen Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held at 16:00 on December 31, 2025, in the company's third conference room, Building 3, No. 7, Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing, through a combination of on-site and communication voting. The company's 2025 third extraordinary shareholders' meeting held on December 31, 2025 reviewed and approved the election of the board of directors. In order to ensure that the current board of directors can start work as soon as possible, with the unanimous consent of all directors, it was decided to hold the first meeting of the company's fifth board of directors on the same day. This meeting was chaired by Mr. Liu Jianhua, the chairman of the company. 9 directors were supposed to be present, but 9 directors were actually present. The company's senior managers attended the meeting. The number of voting participants and the convening procedures of this meeting are in compliance with relevant regulations such as the Company Law and the Articles of Association, and are legal and valid.
2. Review status of board of directors meeting
- Considered and approved the "Proposal on the Election of Chairman of the Fifth Board of Directors of the Company"
In accordance with the relevant provisions of the "Company Law" and other national laws, regulations and normative documents as well as the "Articles of Association", after deliberation by all directors, it was agreed to elect Mr. Liu Jianhua as the chairman of the fifth session of the board of directors of the company, with a term of three years from the date of review and approval by the board of directors.
For details, please refer to the "Announcement on the Completion of the General Election of the Board of Directors and the Appointment of Senior Management and Securities Affairs Representatives" disclosed by the company in the designated information disclosure media.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- Considered and approved the "Proposal on the Election of Members and Chairman of the Special Committee of the Fifth Session of the Board of Directors"
In accordance with the relevant provisions of the "Company Law" and other national laws, regulations and normative documents as well as the "Articles of Association", after deliberation by all directors, it was agreed to elect the members and chairman of the special committee of the fifth board of directors as follows:
(1) Strategy Committee: Mr. Liu Jianhua (Chairman), Ms. Wang Xijuan, Mr. Niu Zhanqi, Mr. Fu Lijia, and Mr. Zhai Yonggong;
(2) Nomination Committee: Mr. Fu Lijia (Chairman), Mr. Liu Jianhua, Mr. Zhai Yonggong;
(3) Audit Committee: Mr. Liu Junyan (Chairman), Mr. Fu Lijia, Mr. Zhai Yonggong, Ms. Wang Xijuan, and Mr. Huang Han;
(4) Remuneration and Appraisal Committee: Mr. Zhai Yonggong (Chairman), Mr. Liu Jianhua, Mr. Liu Junyan;
The term of the above-mentioned special committee members will be three years from the date of review and approval by the board of directors (including the term of independent directors until they leave office at the expiration of six consecutive years of continuous service in the company, at which time the company will re-nominate and elect corresponding members).
For details, please refer to the "Announcement on the Completion of the General Election of the Board of Directors and the Appointment of Senior Management and Securities Affairs Representatives" disclosed by the company in the designated information disclosure media.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- Considered and approved the "Proposal on Appointment of Senior Management of the Company"
In accordance with the "Company Law" and other national laws, regulations and normative documents as well as the relevant provisions of the "Articles of Association", after being nominated by Chairman Mr. Liu Jianhua and reviewed and approved by the Nomination Committee of the Board of Directors, the Company's Board of Directors agreed to appoint Mr. Niu Zhanqi as the President of the Company and Mr. Huang Xiaodong as the Secretary of the Company's Board of Directors. Mr. Huang Xiaodong's qualification as secretary of the board of directors has been reviewed and approved by the Shanghai Stock Exchange. After being nominated by the President, Mr. Niu Zhanqi, and approved by the Nomination Committee and Audit Committee of the Board of Directors, the Board of Directors agreed to appoint Mr. Liu Xiaohan as the Company's Financial Director.
None of the above-mentioned senior managers are prohibited from serving as senior managers of the company as stipulated in the Company Law, nor have they been deemed unfit to serve as senior managers of listed companies by the China Securities Regulatory Commission or the stock exchange. Their qualifications are in compliance with the provisions of the Company Law, the Stock Listing Rules of the Shanghai Stock Exchange, and the Articles of Association. The term of office of the above senior management personnel shall be three years from the date of review and approval by the board of directors. The specific voting details of this proposal are as follows:
3.01 Proposal on Appointment of President of the Company
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
3.02 Proposal on Appointment of the Company’s Financial Director
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
3.03 Proposal on Appointment of Secretary to the Company’s Board of Directors
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
The proposal regarding the appointment of senior management personnel has been reviewed and approved by the Nomination Committee of the Board of Directors, and the appointment of the Chief Financial Officer has been reviewed and approved by the Audit Committee of the Board of Directors.
For details, please refer to the "Announcement on the Completion of the General Election of the Board of Directors and the Appointment of Senior Management and Securities Affairs Representatives" disclosed by the company in the designated information disclosure media.
- The "Proposal on Appointment of the Company's Securities Affairs Representative" was reviewed and approved
Nominated by Mr. Huang Xiaodong, secretary of the board of directors, the board of directors agreed to appoint Ms. Zhang Shina as the company's securities affairs representative to assist the secretary of the board of directors in performing his duties. Ms. Zhang Shina has not been punished by the China Securities Regulatory Commission and other relevant departments or the Shanghai Stock Exchange. She meets the qualifications stipulated in relevant laws and regulations. Her term will be three years from the date of review and approval by the board of directors.
For details, please refer to the "Announcement on the Completion of the General Election of the Board of Directors and the Appointment of Senior Management and Securities Affairs Representatives" disclosed by the company in the designated information disclosure media.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
Announcement is hereby made.
Board of Directors of Beijing Kangchen Pharmaceutical Co., Ltd.
January 5, 2026